Inovio Pharmaceuticals (NASDAQ:INO – Free Report) had its target price lowered by Royal Bank of Canada from $6.00 to $5.00 in a research report sent to investors on Wednesday,Benzinga reports. The ...

Royal Bank of Canada reaffirmed their outperform rating on shares of Five9 (NASDAQ:FIVN – Free Report) in a research note published on Wednesday morning,Benzinga reports. Royal Bank of Canada ...

Investing in stocks need not require you to burn a hole in your pocket. You can invest $70 to $100 every month in these ...

In a noteworthy trading event, TELUS Co. (TSE:T) witnessed its shares cross above the 200-day moving average on Thursday, signaling a potential shift in market momentum. Investors and market analysts ...

For the mid-term outlook covering 2026 and 2027, organic sales growth is projected between 3.5% and 3.7%, slightly below ...

Unfortunately, uncertainty surrounding President Donald Trump's tariff policies, coupled with aggressive federal layoffs, have rattled the markets, and some bank stocks could face credit risks if the ...

Investing.com -- RBC Capital Markets sees an opportunity in UK food retail stocks following a recent sell-off that the bank ...

Discover February's top-performing precious metals stocks, with Sailfish Royalty leading at 11.11% growth. Click here to read ...

Worries about U.S. tariff exposure and weaker oil prices have weighed on shares of the Calgary-based oil and gas producer ...

The economic mood seems to be darkening and that has RBC Capital Markets analysts lowering their price target for the S&P 500 at the end of the year to 6,200 from 6,600. That still implies a roughly ...

Maintaining an “outperform” recommendation for NFI shares, Mr. Murray raised his one-year target to $26 from $24 to reflect ...

The GDP model reflects the damage to growth that's already incurred this year as well as the "sluggish" backdrop for the rest of the year, while a model based on trailing price-to-earnings ratio ...